Sanofi maintained fourth position in consumer health in 2022 , with its strong brands in analgesics and cough cold and allergy remedies positively affected by growing self-treatment during the pandemic and cold season. The ongoing strategic divesture and spin-off aim to accelerate the future growth of its consumer health business. The recent leadership nominations and investment in digitalisation give an indication of Sanofi’s future direction in Asia Pacific.
Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).
This report comes in PPT.
Euromonitor International's report on Sanofi delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Sanofi, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Sanofi.
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and WellbeingSee All of Our Definitions
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!